Acute myocardial infarction in young adults: Prognostic role of angiatensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up

American Heart Journal

Volumn 139, Issue 6, 2000, Pages 979-984

  Brscic, Elvis ^b   Bergerone, Serena ^b   Gagnor, Andrea ^b   Colajanni, Elena ^c   Matullo, Giuseppe ^c   Scaglione, Luca ^a   Cassader, Maurizio ^a   Gaschino, Gianni ^d   Di Leo, Margherita ^e   Brusca, Antonino ^b   Trevi, Gian Paolo ^a,b   Piazza, Alberto ^c  

^a Dipartimento Medicina Interna   (Italy)

^b Divisione di Cardiologia   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d MARIA VITTORIA HOSPITAL   (Italy)

^e Divisione di Cardiologia Ospedale SS Annunziata di Savigliano   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCOPROTEIN IIIA; NITRIC OXIDE SYNTHASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ENZYME ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR BINDING; RISK FACTOR;

EID: 0034041236     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.106165     Document Type: Article

References (31)

1. Zimmerman FH, Cameron A, Fisher LD. Myocardial infarction in young adults: angiographic characterization, risk factor and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol. 26:1995;654-661.
2. Hamsten A, de Faire U. Risk factors for coronary artery disease in families of young men with myocardial infarction. Am J Cardiol. 59:1987;14-19.
3. Wolfe MW, Vacek JL. Myocardial infarction in the young: angiographic features and risk factor analysis of patients with myocardial infarction at or before the age of 35 years. Chest. 94:1988;926-930.
4. Genest JJ, McNamara JR, Salem DN. Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol. 67:1991;1185-1189.
5. Skinner JS, Albers CJ, Goudevenos J. Prospective study of patients aged 55 years or less with acute myocardial infarction between 1981 and 1985: outcome 7 years and beyond. Br Heart J. 74:1995;604-610.
6. Moccetti T, Malacrida R, Pasotti E, for the Investigators of, the Gruppo Italiano, per lo Studio della, Sopravvivenza nell, 'Infarto Miocardico. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Arch Intern Med. 157:1997;865-869.
7. Imazio M, Bobbio M, Bergerone S. Clinical and epidemiological characteristics of juvenile myocardial infarction in Italy: the GISSI experience. G Ital Cardiol. 28:1998;505-512.
8. Roncaglioni MC, Santoro L, D'Avanzo B, EFRIM Investigators. Role of family history in patients with myocardial infarction: an Italian Case-Control study. Circulation. 85:1992;2065-2072.
9. Marenberg ME, Risch N, Berkman LF. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 330:1994;1041-1046.
10. Cambien F, Poirer O, Lecerf L. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factors for myocardial infarction. Nature. 359:1992;641-644.
11. Tiret L, Bonnardeaux A, Poirer O. Synergistic effects of angiotensin-converting enzyme gene and angiotensin II type I receptor gene polymorphisms on risk of myocardial infarction. Lancet. 344:1994;910-913.
12. Luc G, Bard JM, Arveiler D. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb. 14:1994;1412-1419.
13. Tiret L, de Knijff P, Menzel HJ, for the EARS group. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: the EARS study. Arterioscler Thromb. 14:1994;1617-1624.
14. Wang XL, Sim AS, Badenhop RF. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med. 2:1996;41-45.
15. Ichihara S, Yamada Y, Fujimura T. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol. 81:1998;83-86.
16. Weiss EJ, Bray PF, Tayback M. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 334:1996;1090-1094.
17. Report of, the joint International Society, and Federation of, World Health, Organization Task, Force on. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation. 59:1979;607-609.
18. Joint National, Committee on. The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC-V). Arch Intern Med. 153:1993;154-183.
19. Rigat B, Hubert C, Corvol P. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene. Nucleic Acids Res. 20:1992;1433-1440.
20. Katsuya T, Koike G, Yee TW. Association of angiotensinogen gene T 235 variant with increased risk of coronary heart disease. Lancet. 345:1995;1600-1603.
21. Simseck S, Faber NM, Bleeker PM. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele specific restriction enzyme) analysis. Blood. 81:1993;835-840.
22. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 31:1990;545-548.
23. Berenson JS, Srinivasan SR, Bao W, for the Bogalusa heart. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 338:1998;1650-1656.
24. Rosenthal N, Schwartz RS. In search of perverse polymorphisms. N Engl J Med. 338:1998;122-124.
25. Hixson JE, and the Pathobiological Determinants, of Atherosclerosis in, Research Group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb. 11:1991;1237-1244.
26. Kuusi T, Nieminen MS, Ehnholm C. Apolipoprotein E polymorphism and coronary heart disease: increased prevalence of apolipoprotein E4 in angiographically verified coronary patients. Arteriosclerosis. 9:1989;237-241.
27. Eichner JE, Kuller LH, Orchard TJ. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 71:1993;160-165.
28. Samani NJ, O'Toole L, Martin D. Insertion/Deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol. 28:1996;338-344.
29. Chowdhury, TA, Dronsfield, MJ, Jones, AF1994Angiotensin II receptor gene polymorphisms and risk of myocardial infarction.
30. Ridker PM, Hennekens CH, Schmitz C. Pl polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 349:1997;385-388.
31. Scaglione L, Bergerone S, Gaschino G. Lack of relationship between the Pl/Pl polymorphism of glycoprotein IIIa and premature myocardial infarction. European J Clin Invest. 28:1998;385-388.